Strategic Expansion and Index Inclusion Propel European Lithium Forward

European Lithium joins the All Ordinaries Index in 2026, diversifies into titanium via Velta acquisition, and strengthens its balance sheet with asset sales and a share buyback.

A significant strategic shift is underway at European Lithium, marked by a major acquisition, proactive capital management, and an upcoming milestone in its corporate journey. The company is set to join Australia's All Ordinaries Index on March 23, 2026, following a quarterly review decision by S&P Dow Jones Indices announced on March 6. This index inclusion is expected to prompt portfolio rebalancing by funds that track the benchmark, potentially generating technical buying interest.

Broadening the Portfolio Beyond Lithium

In a decisive move to diversify its operations, European Lithium finalized an all-share transaction in late January 2026 to acquire U.S.-based titanium producer Velta Holding. The deal, valued at 173 million newly issued ordinary shares, grants the company access to Velta's production and processing facilities located in Ukraine. This acquisition strategically positions European Lithium within the titanium supply chain, a metal critical for defense, aerospace, medical technology, and energy generation sectors. The expansion represents a deliberate strategic pivot to reduce reliance on the often volatile lithium market and establish a foothold in other essential materials.

This foray into critical materials outside higher-risk jurisdictions aligns with growing geopolitical emphasis on securing supply chains for defense technology and advanced industrial applications. The Velta deal substantially widens European Lithium's exposure across the spectrum of strategic raw materials.

Fortifying the Balance Sheet

Concurrent with its operational expansion, the company has been actively managing its financial resources. Its treasury received a substantial boost from the partial divestment of its stake in Critical Metals Corp. An initial sale of five million shares in January 2026 generated 124 million Australian dollars. This was followed by a further disposal of 2.5 million shares in February for an additional 45 million dollars. These transactions have elevated the firm's cash reserves to approximately 356 million Australian dollars.

Despite these sales, European Lithium retains a significant holding of 45.5 million shares in Critical Metals Corp. This remaining stake provides the company with continued indirect exposure to the Tanbreez rare earths project in Greenland. Management confirmed in February that no further share sales are planned for a four-month period, a statement market observers interpret as leaving the door open for potential future transactions.

Further demonstrating its capital management strategy, the company is executing a share buyback program. Managed by Evolution Capital, the initiative authorizes the repurchase of up to 135 million ordinary shares, utilizing the legally permitted limit of ten percent of issued capital. The program was originally scheduled to run until March 31, 2026.

Implications of Index Membership

The formal inclusion in the All Ordinaries Index takes effect before market open on March 23. Index-tracking funds are required to adjust their holdings to reflect the new composition, which can create technical demand for the stock. Admission to this key Australian benchmark is based on criteria including market capitalization and liquidity—metrics that European Lithium's recent financial activities have likely strengthened.

S&P Dow Jones Indices indicated that its latest quarterly review reflects a broader market rotation toward resource and growth-oriented companies within the Australian equity landscape. European Lithium's upcoming index debut is a direct result of this structural shift in the benchmark's composition.